End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.647 USD | +6.24% | +0.47% | -76.04% |
May. 09 | Earnings Flash (NUTX) NUTEX HEALTH Posts Q1 Revenue $67.5M | MT |
May. 09 | Nutex Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 284M | Sales 2025 * | 330M | Capitalization | 32.07M |
---|---|---|---|---|---|
Net income 2024 * | -11M | Net income 2025 * | -7M | EV / Sales 2024 * | 0.11 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.1 x |
P/E ratio 2024 * |
-2.16
x | P/E ratio 2025 * |
-4.31
x | Employees | 800 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 56.47% |
1 day | +6.24% | ||
1 week | +0.47% | ||
Current month | +6.94% | ||
1 month | -44.70% | ||
3 months | -61.32% | ||
6 months | -82.75% | ||
Current year | -76.04% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Vo
CEO | Chief Executive Officer | 51 | 22-03-31 |
Jon Bates
DFI | Director of Finance/CFO | - | 22-06-29 |
President | 52 | 22-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
President | 52 | 22-02-28 | |
Mitchell Creem
BRD | Director/Board Member | 63 | 22-03-31 |
Thomas Vo
CEO | Chief Executive Officer | 51 | 22-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +9.11% | - | |
0.00% | 0 M€ | +3.88% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 0.66 | +2.01% | 384,895 |
24-05-08 | 0.647 | +6.24% | 163,038 |
24-05-07 | 0.609 | -9.46% | 366,922 |
24-05-06 | 0.6726 | -1.06% | 173,294 |
24-05-03 | 0.6798 | +5.56% | 184,290 |
End-of-day quote Nasdaq, May 07, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-76.04% | 32.71M | |
+18.92% | 84.31B | |
-29.48% | 69.9B | |
+9.65% | 29.06B | |
-0.14% | 17.01B | |
-9.30% | 17.38B | |
+0.20% | 15.35B | |
+5.25% | 12.91B | |
+68.96% | 12.47B | |
-2.88% | 11.9B |
- Stock Market
- Equities
- NUTX Stock